Skip to main content
. 2012 Jan 12;7:235–242. doi: 10.2147/IJN.S27722

Figure 6.

Figure 6

Nuclear morphologic changes of K562 leukemia cells after different treatments for 48 hours: (A) untreated cells as control, (B) titanium dioxide nanoparticles, (C) daunorubicin alone, and (D) daunorubicin-titanium dioxide nanocomposites. Concentrations of daunorubicin and titanium dioxide nanoparticles are 0.5 μg/mL and 10 μg/mL, respectively.

Notes: Magnification: ×400. Arrows indicate cells with apoptotic nuclear condensation and fragmentation.